Telmisartan and Ocrevus drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Telmisartan (telmisartan) and Ocrevus (ocrelizumab). Common drug interactions include neuropathy peripheral among females and fatigue among males.
The phase IV clinical study analyzes what interactions people have when they take Telmisartan and Ocrevus. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.
What is Telmisartan?
Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.
What is Ocrevus?
Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 56,583 Ocrevus users. Check the latest studies of Ocrevus.
61 people who take Telmisartan and Ocrevus together, and have interactions are studied.

What are the common drug interactions of Telmisartan and Ocrevus, by gender? *:
female:
- Neuropathy peripheral (surface nerve damage)
- Nightmare (unpleasant dream)
- Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
- Pharyngeal disorder
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
- Spinal pain (pain in spine)
- Cough
- Hemiparesis (weakness on one side of the body)
- Hypersensitivity
- Agitation (state of anxiety or nervous excitement)
male:
- Fatigue (feeling of tiredness)
- Feeling hot
- Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)
- Productive cough
- Infusion related reaction
- Hypoaesthesia (reduced sense of touch or sensation)
- Sinusitis (inflammation of sinus)
- Arthropathy
- Erythema (redness of the skin)
- Influenza
What are the common drug interactions of Telmisartan and Ocrevus, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Asthenia (weakness)
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Vomiting
40-49:
- Influenza like illness
- Lymphadenopathy (disease or enlargement of lymph nodes)
- Migraine (headache)
- Neck pain
- Neuropathy peripheral (surface nerve damage)
- Nightmare (unpleasant dream)
- Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
- Pain
- Pharyngeal disorder
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
50-59:
- Fatigue (feeling of tiredness)
- Cough
- Nasopharyngitis (inflammation of the nasopharynx)
- Asthenia (weakness)
- Depression
- Infusion related reaction
- Arthropathy
- Erythema (redness of the skin)
- Feeling hot
- Hypoaesthesia (reduced sense of touch or sensation)
60+:
- Fatigue (feeling of tiredness)
- Feeling hot
- Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)
- Productive cough
- Tremor (trembling or shaking movements in one or more parts of your body)
- Asthenia (weakness)
- Blood potassium decreased
- Dizziness
- Hemiparesis (weakness on one side of the body)
- Pain
What are the existing conditions these people have? *
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 43 people, 70.49%
- Depression: 10 people, 16.39%
- Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 7 people, 11.48%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 9.84%
- Pain: 5 people, 8.20%
- Stress And Anxiety: 4 people, 6.56%
- Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 6.56%
- Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 6.56%
- Fatigue (feeling of tiredness): 4 people, 6.56%
- Acne (skin problems that cause pimples): 4 people, 6.56%
* Approximation only. Some reports may have incomplete information.
Do you take Telmisartan and Ocrevus?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Telmisartan (9,163 reports)
- Ocrevus (56,583 reports)
Browse all drug interactions of Telmisartan and Ocrevus:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Telmisartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ocrevus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Telmisartan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ocrevus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on telmisartan and ocrelizumab (the active ingredients of Telmisartan and Ocrevus, respectively), and Telmisartan and Ocrevus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Diflucan and Road Traffic Accident for Women aged 40-49 - 3 seconds ago
- Ketek and Vision Blurred for Men aged 60+ - 4 seconds ago
- Drug interactions of Rebetol and Naprosyn - 5 seconds ago
- Could Klor-Con cause Acetabulum Fracture? - 8 seconds ago
- Could Ativan cause Localised Infection? - 9 seconds ago
- Could Lisinopril cause Pleural Effusion? - 23 seconds ago
- Could Mupirocin cause Tenderness? - 28 seconds ago
- Could Intron A cause Urination - Painful? - 29 seconds ago
- Pseudotumor Cerebri and drugs of ingredients of cephalexin - 30 seconds ago
- Profen and Duodenal Ulcer Perforation for Women aged 60+ - 33 seconds ago